Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors

Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors

US Patent 11384140 · Granted Jul 12, 2022

Estimated economic value: $191,717,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody therapies for human immunodeficiency virus (HIV)2025
Anti-HIV antibody 10-1074 variants2025
Facilities and processes to produce biotherapeutics2025
Implementing a generative machine learning architecture to produce training data2024
Human IL-23 antigen binding proteins2024
Interleukin-2 muteins for the expansion of T-regulatory cells2024
ST2 antigen binding proteins2024
Autoencoder with generative adversarial network to generate protein sequences2024
Antibody therapies for human immunodeficiency virus (HIV)2023
Predicting molecular properties of molecular variants using residue-specific mol2023
Expression from transposon-based vectors and uses2023
Inducible expression from transposon-based vectors and uses2023